🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/02/2011 | 5,60 | 5,68 | 5,60 | 5,68 | +1,45% | 1,34% | 181.299 |
| 07/02/2011 | 5,46 | 5,61 | 5,46 | 5,60 | +2,28% | 2,62% | 112.370 |
| 04/02/2011 | 5,42 | 5,51 | 5,42 | 5,47 | +0,92% | 1,73% | 84.959 |
| 03/02/2011 | 5,56 | 5,56 | 5,40 | 5,42 | -2,47% | 3,03% | 121.828 |
| 02/02/2011 | 5,49 | 5,60 | 5,49 | 5,56 | +1,02% | 1,93% | 60.273 |
| 01/02/2011 | 5,45 | 5,51 | 5,42 | 5,50 | +1,38% | 1,72% | 76.463 |
| 31/01/2011 | 5,43 | 5,48 | 5,40 | 5,43 | +0,58% | 1,49% | 138.499 |
| 28/01/2011 | 5,46 | 5,46 | 5,40 | 5,40 | -1,14% | 1,14% | 217.848 |
| 27/01/2011 | 5,49 | 5,58 | 5,40 | 5,46 | -0,12% | 3,41% | 138.660 |
| 26/01/2011 | 5,45 | 5,56 | 5,43 | 5,46 | +0,81% | 2,40% | 66.685 |
| 25/01/2011 | 5,44 | 5,50 | 5,40 | 5,42 | -1,02% | 1,83% | 75.181 |
| 24/01/2011 | 5,39 | 5,48 | 5,39 | 5,48 | +1,27% | 1,74% | 55.784 |
| 21/01/2011 | 5,55 | 5,55 | 5,40 | 5,41 | -1,37% | 2,59% | 110.447 |
| 20/01/2011 | 5,52 | 5,68 | 5,48 | 5,48 | -1,01% | 3,62% | 104.355 |
| 19/01/2011 | 5,61 | 5,63 | 5,53 | 5,54 | -1,66% | 1,89% | 189.475 |
| 18/01/2011 | 5,68 | 5,70 | 5,62 | 5,63 | -1,20% | 1,32% | 78.868 |
| 14/01/2011 | 5,65 | 5,70 | 5,61 | 5,70 | +0,88% | 1,55% | 105.477 |
| 13/01/2011 | 5,69 | 5,69 | 5,61 | 5,65 | -0,66% | 1,43% | 123.912 |
| 12/01/2011 | 5,66 | 5,73 | 5,63 | 5,69 | +1,22% | 1,65% | 59.151 |
| 11/01/2011 | 5,65 | 5,65 | 5,60 | 5,62 | -0,44% | 0,99% | 120.706 |
| 10/01/2011 | 5,65 | 5,66 | 5,60 | 5,65 | -0,44% | 1,10% | 247.664 |
| 07/01/2011 | 5,71 | 5,71 | 5,59 | 5,67 | -0,55% | 2,08% | 177.132 |
| 06/01/2011 | 5,78 | 5,78 | 5,69 | 5,70 | -1,51% | 1,62% | 161.743 |
| 05/01/2011 | 5,66 | 5,79 | 5,59 | 5,79 | +2,20% | 3,53% | 198.772 |
| 04/01/2011 | 5,64 | 5,68 | 5,60 | 5,66 | +1,00% | 1,44% | 224.741 |
| 03/01/2011 | 5,60 | 5,67 | 5,59 | 5,61 | +0,78% | 1,45% | 166.552 |
| 31/12/2010 | 5,59 | 5,59 | 5,54 | 5,56 | +0,11% | 0,89% | 113.973 |
| 30/12/2010 | 5,56 | 5,61 | 5,56 | 5,56 | +0,00% | 1,01% | 89.127 |
| 29/12/2010 | 5,60 | 5,61 | 5,55 | 5,56 | -0,78% | 1,12% | 122.469 |
| 28/12/2010 | 5,58 | 5,63 | 5,53 | 5,60 | +0,11% | 1,67% | 143.949 |